Search - tctmd.com

Displaying 1 - 20 of 103

Sort: Relevancy | Date

Presentation TCT 2025

Lecture: Refractory Angina: Don’t Treat the Coronaries, Put in a Coronary Sinus Reducer

Presenter: Timothy D. Henry

October 28, 2025

Presentation TCT 2025

TCT 793: Sex Specific Outcomes of Treating Patients with Refractory Angina with the Coronary Sinus Reducer: One-year outcomes from the REDUCER-I Registry

Presenter: Stefan Verheye

October 26, 2025

Presentation TCT 2025

TCT 789: Efficacy and Safety of Coronary Sinus Reducer Implantation in Refractory Angina: A Systematic Review and Meta-Analysis. CSR implantation reduces angina severity and quality of life while maintaining low complication rates.

Presenter: Mohammad Reza Movahed

October 26, 2025

Presentation TCT 2025

TCT 1621: Coronary Sinus Reducer Implantation for Refractory Angina in an LVAD-Supported Patient With Ischemic Cardiomyopathy

Presenter: Aimane Mechroubi

October 25, 2025

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Todd Neale

August 13, 2025

Podcast TCTMD Talking Points

The ORBITA-COSMIC Trial

February 12, 2025

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

$TCT 402: The Efficacy of Coronary Sinus Reducer in Patients With Refractory Angina Caused by Chronic Total Occlusion (CTO)$

Presentation TCT 2024

TCT 402: The Efficacy of Coronary Sinus Reducer in Patients With Refractory Angina Caused by Chronic Total Occlusion (CTO)

Presenter: Maayan Konigstein

October 27, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

Presentation TCT 2023

Discussion & Closing Comments

Presenter: Timothy Henry

October 24, 2023

Presentation TCT 2023

The Future of Clinical Data for The Reducer

Presenter: Megha Prasad

October 24, 2023

Presentation TCT 2023

The Coronary Sinus Reducer

Presenter: Stefan Verheye

October 24, 2023

Presentation TCT 2023

Patients – Where are They?

Presenter: Timothy Henry

October 24, 2023

Presentation TCT 2023

Angina – The Scope of the Challenge

Presenter: Allen Jeremias

October 24, 2023

NY State to Exclude Emergency PCI Cases From Public Outcomes Reports

News Daily News

NY State to Exclude Emergency PCI Deaths From Physician-Level Public Reports

Todd Neale

January 04, 2023

News Daily News

No Benefit to More-Complete Coronary Revascularization Before TAVI, Registry Shows

Todd Neale

December 29, 2022

News Opinion Conversations in Cardiology

Conversations in Cardiology: ISCHEMIA’s Lasting Fallout

December 29, 2022

Advertisement

Lecture: Refractory Angina: Don’t Treat the Coronaries, Put in a Coronary Sinus Reducer

TCT 793: Sex Specific Outcomes of Treating Patients with Refractory Angina with the Coronary Sinus Reducer: One-year outcomes from the REDUCER-I Registry

TCT 789: Efficacy and Safety of Coronary Sinus Reducer Implantation in Refractory Angina: A Systematic Review and Meta-Analysis. CSR implantation reduces angina severity and quality of life while maintaining low complication rates.

TCT 1621: Coronary Sinus Reducer Implantation for Refractory Angina in an LVAD-Supported Patient With Ischemic Cardiomyopathy

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

The ORBITA-COSMIC Trial

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

TCT 402: The Efficacy of Coronary Sinus Reducer in Patients With Refractory Angina Caused by Chronic Total Occlusion (CTO)

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

What’s Going to Be Hot at ACC 2024

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Discussion & Closing Comments

The Future of Clinical Data for The Reducer

The Coronary Sinus Reducer

Patients – Where are They?

Angina – The Scope of the Challenge

NY State to Exclude Emergency PCI Deaths From Physician-Level Public Reports

No Benefit to More-Complete Coronary Revascularization Before TAVI, Registry Shows

Conversations in Cardiology: ISCHEMIA’s Lasting Fallout

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content